CoChat

Neonatal Screening: Identification of Children with 11β-Hydroxylase Deficiency by Second-Tier Testing

Janzen, Nils, Riepe, Felix G., Peter, Michael, Sander, Stefanie, Steuerwald, Ulrike, Korsch, Eckhard, Krull, Friedrich, Müller, Hermann L., Heger, Sabine, Brack, Christoph, Sander, Johannes · 2012 · Hormone Research in Paediatrics

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: 21-Hydroxylase deficiency (21-OHD) is the target disease of newborn screening for congenital adrenal hyperplasia (CAH). We describe the additional detection of patients suffering from 11β-hydroxylase deficiency (11-OHD) by second-tier testing. METHOD: Over a period of 5 years, screening for CAH was done in a total of 986,098 newborns by time-resolved immunoassay (DELFIA®) for 17α-hydroxyprogesterone (17-OHP). Positive samples were subsequently analyzed in an LC-MS/MS second-tier test including 17-OHP, cortisol, 11-deoxycortisol, 4-androstenedione and 21-deoxycortisol. RESULTS: In addition to 78 cases of 21-OHD, 5 patients with 11-OHD were identified. Diagnostic parameters were a markedly elevated concentration of 11-deoxycortisol in the presence of a low level of cortisol. Androstenedione was also increased. In contrast to 21-OHD, concentrations of 21-deoxycortisol were normal. CONCLUSION: Steroid profiling in newborn blood samples showing positive results in immunoassays for 17-OHP allows for differentiating 21-OHD from 11-OHD. This procedure may not detect all cases of 11-OHD in the newborn population because there may be samples of affected newborns with negative results for 17-OHP in the immunoassay.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000337974

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 10

  1. Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW: Corrected 17 ␣ -hydroxyprogester- one values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants. Ann Clin Lab Sci 2008; 38: 235-240.
  2. Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J: Newborn screening for congenital adrenal hyperpla- sia: additional steroid profile using liquid chromatography-tandem mass spectrome- try. J Clin Endocrinol Metab 2007; 92: 2581- 2589.
  3. Janzen N, Sander S, Terhardt M, Peter M, Sander J: Fast and direct quantification of adrenal steroids by tandem mass spectrom- etry in serum and dried blood spots. J Chro- matogr B Analyt Technol Biomed Life Sci 2008; 861: 117-122.
  4. Krone N, Riepe FG, Gotze D, Korsch E, Ris- ter M, Commentz J, Partsch CJ, Grotzinger J, Peter M, Sippell WG: Congenital adrenal hy- perplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair dele- tion in the CYP11B1 gene. J Clin Endocrinol Metab 2005; 90: 3724-3730.
  5. Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M: Use of steroid profiling by UPLC-MS/MS as a second-tier test in newborn screening for congenital adrenal hyperplasia: the Utah ex- perience. Pediatr Res 2009; 66: 230-235.
  6. De Jesus VR, Simms DA, Schiffer J, Kennedy M, Mei JV, Hannon WH: Pilot proficiency testing study for second tier congenital ad- renal hyperplasia newborn screening. Clin Chim Acta 2010; 411: 1684-1687.
  7. Rauh M: Steroid measurement with LC-MS/ MS in pediatric endocrinology. Mol Cell En- docrinol 2009; 301: 272-281.
  8. Honda A, Yamashita K, Miyazaki H, Shirai M, Ikegami T, Xu G, Numazawa M, Hara T, Matsuzaki Y: Highly sensitive analysis of ste- rol profiles in human serum by LC-ESI-MS/ MS. J Lipid Res 2008; 49: 2063-2073.
  9. Janzen N, Sander S, Terhardt M, Steuerwald U, Peter M, Das AM, Sander J: Rapid steroid hormone quantification for congenital adre- nal hyperplasia in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry. Steroids 2011; 76: 1437-1442.
  10. Nimkarn S, New MI: Steroid 11 ␤ -hydroxy- lase deficiency congenital adrenal hyperpla- sia. Trends Endocrinol Metab 2008; 19: 96- 99.

Cited by

See all 39

Metadata

Authors
Janzen, N., Riepe, F. G., Peter, M., Sander, S., Steuerwald, U., Korsch, E., Krull, F., Müller, H. L., Heger, S., Brack, C., & Sander, J.
Affiliations
  • University Hospitals of the Ruhr-University of Bochum (DE)
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Kliniken der Stadt Köln (DE)
  • Kinderkrankenhaus auf der Bult (DE)
Venue
Hormone Research in Paediatrics
Publisher
S. Karger AG
Published
2012
Volume
77
Issue
3
Pages
195-199
ISSN
  • 1663-2818 (ISSN-L)
  • 1663-2826
OpenAlex
W1972295191
Cited by
37
References
12
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 3
FWCI
0.51
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Hormone Research in Paediatrics (publishedVersion)
  • PubMed (publishedVersion)
  • Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
11beta-hydroxylase deficiency, congenital adrenal hyperplasia, 21-hydroxylase deficiency, newborn screening, second-tier testing, 17-hydroxyprogesterone, 11-deoxycortisol, androstenedione, cortisol, steroid profiling, LC-MS/MS
MeSH terms
Adrenal Hyperplasia, Congenital, Androstenedione, Cortodoxone, False Positive Reactions, Female, Humans, Hydrocortisone, Infant, Infant, Newborn, Male, Steroid 11-beta-Hydroxylase, Neonatal Screening, 17-alpha-Hydroxyprogesterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.